CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 279 filers reported holding CYTOKINETICS INC in Q4 2022. The put-call ratio across all filers is 0.54 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $427 | -16.4% | 14,500 | -7.5% | 0.04% | -32.8% |
| Q2 2023 | $511 | -63.3% | 15,678 | -48.4% | 0.06% | -54.0% |
| Q4 2022 | $1,392 | -99.8% | 30,390 | +104.1% | 0.14% | +95.8% |
| Q3 2022 | $721,000 | +219.0% | 14,889 | +158.5% | 0.07% | +173.1% |
| Q2 2022 | $226,000 | -31.7% | 5,760 | -65.6% | 0.03% | -21.2% |
| Q2 2021 | $331,000 | -29.9% | 16,749 | -23.2% | 0.03% | -56.6% |
| Q3 2020 | $472,000 | +137.2% | 21,795 | +16.0% | 0.08% | +137.5% |
| Q4 2019 | $199,000 | +12.4% | 18,795 | +28.7% | 0.03% | -3.0% |
| Q2 2017 | $177,000 | +20.4% | 14,602 | +20.7% | 0.03% | -15.4% |
| Q4 2016 | $147,000 | – | 12,102 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 223,382 | $6,580,834 | 7.72% |
| Finepoint Capital LP | 431,693 | $12,717,676 | 6.33% |
| Saturn V Capital Management LP | 495,168 | $14,587,649 | 6.11% |
| Logos Global Management LP | 1,250,000 | $36,825,000 | 4.91% |
| DAFNA Capital Management LLC | 479,538 | $14,127,189 | 4.39% |
| PFM Health Sciences, LP | 2,399,545 | $70,690,596 | 3.33% |
| Boxer Capital, LLC | 2,100,000 | $61,866,000 | 3.29% |
| Integral Health Asset Management, LLC | 800,000 | $23,568,000 | 3.26% |
| GREAT POINT PARTNERS LLC | 600,000 | $17,676,000 | 3.22% |
| Nicholas Investment Partners, LP | 942,137 | $27,755,356 | 2.07% |